Proactiveinvestors recommends
Additional Information
Market: NYSE
Sector: Chemicals
EPIC: EMN
Latest Price: 53.92  (-0.48% Descending)
52-week High: 54.69
52-week Low: 33.31
Market Cap: 7,570.42M
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Eastman Chemical Company
www.eastman.com

Eastman Chemical Company is a global chemical company engaged in the manufacture and sale of a portfolio of more than 1,200 chemicals, plastics and fibres products.

Full Eastman Chemical Company profile here
Pdf

Arsenal Capital Partners sells chemicals business Genovique to Eastman

17th Mar 2010, 1:45 pm
Arsenal Capital Partners sells chemicals business Genovique to Eastman

Eastman Chemical Company (“Eastman”)(NYSE:EMN) has entered into an agreement to acquire Genovique Specialties from private equity group, Arsenal Capital Partners.


The Tennessee based chemical group’s acquisition of Genovique will allow it to take a significant slice of the global benzoate plasticizers market. Genovique produces benzoic acid, sodium benzoate and other specialty plasticizers used in adhesives, sealants, coatings and Polyvinyl chloride (PVC). The company has benzoate esters manufacturing capabilities in North America, Europe and Asia, which generate approximately US$135 million in annual revenues.


Arsenal Capital Partners acquired Genovique in 2005.


"We are very pleased with the support of Arsenal Capital who helped the Executive Team carry out the transformation of Genovique Specialties into a high growth, innovative, specialty chemicals company,” Ross McMillan, CEO of Genovique, said. “Arsenal's understanding of the chemical industry and their commitment to and support of my management team were instrumental in delivering the exceptional results the company has achieved over the last five years. We believe Eastman is an excellent choice to steward Genovique into the next phase of global development and growth."


Financial details of the transaction were not disclosed.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.